BeOne Medicines (ONCN) Stock Statistics & Valuation Metrics
Total Valuation
BeOne Medicines has a market cap or net worth of MXN 777.76B. The enterprise value is MXN 29.79B.
- Market Cap
- MXN 777.76B
- Enterprise Value
- MXN 29.79B
Share Statistics
BeOne Medicines has 109,786,920 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 109,786,920
- Owned by Insiders
- 64.42%
- Owned by Institutions
- 0.42%
Financial Efficiency
BeOne Medicines’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.74%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.04
- Return on Invested Capital (ROIC)
- 4.74%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 445.25K
- Profits Per Employee
- 23.91K
- Employee Count
- 12,000
- Asset Turnover
- 0.65
- Inventory Turnover
- 1.10
Valuation Ratios
The current PE Ratio of BeOne Medicines is 25.05. BeOne Medicines’s PEG ratio is -0.41.
- PE Ratio
- 25.05
- PS Ratio
- 6.37
- PB Ratio
- 10.52
- Price to FCF
- 29.77
- Price to Operating Cash Flow
- 36.46
- PEG Ratio
- -0.41
Income Statement
In the last 12 months, BeOne Medicines had revenue of 5.34B and earned 286.93M in profits. Earnings per share was 33.80.
- Revenue
- 5.34B
- Gross Profit
- 4.67B
- Operating Income
- 447.14M
- Pretax Income
- 416.85M
- Net Income
- 286.93M
- EBITDA
- 616.77M
- Earnings Per Share (EPS)
- 33.80
Cash Flow
In the last 12 months, operating cash flow was 1.69B and capital expenditures -443.33M, giving a free cash flow of 1.24B billion.
- Operating Cash Flow
- 1.69B
- Free Cash Flow
- 1.24B
- Free Cash Flow per Share
- 11.81
Dividends & Yields
BeOne Medicines pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.36%
- Earnings Yield
- 1.21%
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 2530.00
- 200-Day Moving Average
- 2530.00
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
BeOne Medicines upcoming earnings date is Nov 06, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 05, 2026
- Next Earnings Date
- Nov 06, 2026
- Ex-Dividend Date
- ―
Financial Position
BeOne Medicines as a current ratio of 3.41, with Debt / Equity ratio of 45.85%
- Current Ratio
- 3.41
- Quick Ratio
- 3.08
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- -4.13
- Interest Coverage Ratio
- 7.68
Taxes
In the past 12 months, BeOne Medicines has paid 129.92M in taxes.
- Income Tax
- 129.92M
- Effective Tax Rate
- 0.31
Enterprise Valuation
BeOne Medicines EV to EBITDA ratio is 31.48, with an EV/FCF ratio of 26.77.
- EV to Sales
- 5.73
- EV to EBITDA
- 31.48
- EV to Free Cash Flow
- 26.77
- EV to Operating Cash Flow
- 23.63
Balance Sheet
BeOne Medicines has MXN 5.10B in cash and marketable securities with MXN 1.14B in debt, giving a net cash position of MXN 3.95B billion.
- Cash & Marketable Securities
- MXN 5.10B
- Total Debt
- MXN 1.14B
- Net Cash
- MXN 3.95B
- Net Cash Per Share
- MXN 36.02
- Tangible Book Value Per Share
- MXN 45.83
Margins
Gross margin is 87.82%, with operating margin of 15.05%, and net profit margin of 10.68%.
- Gross Margin
- 87.82%
- Operating Margin
- 15.05%
- Pretax Margin
- 14.15%
- Net Profit Margin
- 10.68%
- EBITDA Margin
- 18.19%
- EBIT Margin
- 15.68%
Analyst Forecast
The average price target for BeOne Medicines is MXN 8,067.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- MXN 8,067.50
- Price Target Upside
- 218.87% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 13
- Revenue Growth Forecast
- 22.04%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 8
- AI Score
- ―